Your browser doesn't support javascript.
loading
Control of type 2 diabetes mellitus among general practitioners in private practice in nine countries of Latin America
Lopez Stewart, Gloria; Tambascia, Marcos; Rosas Guzmán, Juan; Etchegoyen, Federico; Ortega Carrión, Jorge; Artemenko, Sofia.
  • Lopez Stewart, Gloria; Latin American Diabetes Association.
  • Tambascia, Marcos; University of Campinas. Campinas. BR
  • Rosas Guzmán, Juan; Latin American Diabetes Association.
  • Etchegoyen, Federico; Hospital Universitario Austral. Buenos Aires. AR
  • Ortega Carrión, Jorge; Clinica de la FAE Quito. Quito. EC
  • Artemenko, Sofia; GlaxoSmithKline Inc. North Carolina. US
Rev. panam. salud pública ; 22(1): 12-20, jul. 2007. graf, tab
Article in English | LILACS | ID: lil-463636
ABSTRACT

OBJECTIVES:

To better understand how diabetes care and control are being administered by general practitioners/nonspecialists in private practice in nine countries of Latin America, and to identify the most significant patient- and physician-related barriers to care.

METHODS:

A multicenter, cross-sectional, epidemiological survey was conducted in nine countries in Latin America Argentina, Brazil, Chile, Costa Rica, Ecuador, Guatemala, Mexico, Peru, and Venezuela. General practitioners in private practice were asked to provide care and control data for patients 18 to 75 years of age with type 2 diabetes mellitus (T2DM), including demographics, medical and medication history, laboratory exams, and information on the challenges of patient management.

RESULTS:

Of the 3 592 patient questionnaires returned by 377 physicians, 60 percent of the patients had a family history of diabetes, 58 percent followed a poor diet, 71 percent were sedentary, and 79 percent were obese or overweight. Poor glycemic control (fasting blood glucose > 110 mg/dL) was observed in 78 percent of patients. The number of patients with HbA1c < 7.0 percent was 43.2 percent. Glycemic control decreased significantly with increased duration of T2DM. Comorbid conditions associated with T2DM were observed in 86 percent of patients; insulin use and comorbid conditions, especially those associated with microvascular complications, increased significantly disease duration. Ensuring compliance with recommended diet and exercise plans was the most-cited patient management challenge.

CONCLUSIONS:

Blood glucose levels are undercontrolled in T2DM patients in the private health care system in Latin America, particularly among those who have had the disease the longest (>15 years). Considering the differences between private and public health care in Latin America, especially regarding the quality of care and access to medication, further studies are called for in the public...
RESUMEN

OBJETIVOS:

Comprender mejor cómo los médicos generales/no especialistas del sector privado atienden y controlan la diabetes en nueve países de América Latina e identificar los principales problemas relacionados con el paciente y el médico, que obstaculizan la atención.

MÉTODOS:

Se realizó un estudio epidemiológico, multicéntrico, transversal, en nueve países de América Latina Argentina, Brasil, Chile, Costa Rica, Ecuador, Guatemala, México, Perú y Venezuela. Se pidió a los médicos generales del sector privado la información sobre la atención y el control de sus pacientes de 18 a 75 años de edad con diabetes mellitus tipo 2 (DMT2), así como los datos demográficos, la historia clínica y de medicación, las pruebas de laboratorio e información sobre los retos relacionados con la atención del paciente.

RESULTADOS:

De los 3 592 cuestionarios de pacientes entregados por 377 médicos, 60 por ciento de los pacientes tenían antecedentes familiares de diabetes, 58 por ciento seguían una dieta inadecuada, 71 por ciento eran sedentarios y 79 por ciento presentaban obesidad o sobrepeso. Se observó un inadecuado control glucémico (glucemia en ayunas > 110 mg/dL) en 78 por ciento de los pacientes. La proporción de pacientes con HbA1c < 7,0 por ciento fue de 43,2 por ciento. El control glucémico se redujo significativamente al aumentar la duración de la DMT2. En 86 por ciento de los pacientes se encontraron enfermedades concurrentes asociadas con la DMT2; el uso de insulina y las enfermedades concurrentes -especialmente las asociadas con complicaciones microvasculares- incrementaron significativamente la duración de la diabetes. En cuanto al tratamiento de los pacientes, el reto más frecuentemente citado fue garantizar la adhesión a la dieta y al plan de ejercicios recomendados.

CONCLUSIONES:

Los niveles de glucemia no están suficientemente controlados en los pacientes con DMT2 que se atienden en el sistema privado de salud de América Latina, particularmente...
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Private Practice / Practice Patterns, Physicians&apos; / Family Practice Type of study: Controlled clinical trial / Observational study / Prevalence study / Prognostic study / Risk factors Limits: Adolescent / Adult / Aged / Female / Humans / Male Language: English Journal: Rev. panam. salud pública Journal subject: Public Health Year: 2007 Type: Article Affiliation country: Argentina / Brazil / Ecuador / United States Institution/Affiliation country: Clinica de la FAE Quito/EC / GlaxoSmithKline Inc/US / Hospital Universitario Austral/AR / University of Campinas/BR

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Private Practice / Practice Patterns, Physicians&apos; / Family Practice Type of study: Controlled clinical trial / Observational study / Prevalence study / Prognostic study / Risk factors Limits: Adolescent / Adult / Aged / Female / Humans / Male Language: English Journal: Rev. panam. salud pública Journal subject: Public Health Year: 2007 Type: Article Affiliation country: Argentina / Brazil / Ecuador / United States Institution/Affiliation country: Clinica de la FAE Quito/EC / GlaxoSmithKline Inc/US / Hospital Universitario Austral/AR / University of Campinas/BR